leisure time -WSS

leisure time

author：entertainment 2025-09-29 01:09:18 - browse：3345

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： The Harvard botanist who searched for psychedelics in the Amazon

knowledge

WSS

A solution to the after

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Alabama IVF ruling threatens families facing fatal genetic disease

Neuroscience renaissance leads to new crop of psychiatric drugs

Change Healthcare cyberattack shows risk of industry consolidation

Virtual repurposing can help discover new uses for existing drugs

knowledge

leisure time

knowledge

Virginia high school admissions case could be legal follow

Change Healthcare cyberattack shows risk of industry consolidation

Cancer drug shortages should be causing more outrage

NEJM study measures Covid brain fog, impact on IQ

Peter Hotez and the public health issue of online harassment

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Psychedelics group wrestles with new pharma identity

Cholera vaccine supplies dangerously low, outbreaks surging

explore

Alabama frozen embryo ruling has major implications for IVF clinics

Medicare Advantage isn’t working — for anyone

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

5 ways to address the shortage of health care workers

Virtual repurposing can help discover new uses for existing drugs

hotspot

hotspot

knowledge

hotspot